• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌中的肿瘤干细胞:干性调控的内在和外在分子机制。

Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.

机构信息

Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, China.

Department of Clinical Oncology, The University of Hong Kong, Hong Kong 999077, China.

出版信息

Int J Mol Sci. 2022 Oct 14;23(20):12327. doi: 10.3390/ijms232012327.

DOI:10.3390/ijms232012327
PMID:36293184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9604119/
Abstract

Hepatocellular carcinoma (HCC) remains the most predominant type of liver cancer with an extremely poor prognosis due to its late diagnosis and high recurrence rate. One of the culprits for HCC recurrence and metastasis is the existence of cancer stem cells (CSCs), which are a small subset of cancer cells possessing robust stem cell properties within tumors. CSCs play crucial roles in tumor heterogeneity constitution, tumorigenesis, tumor relapse, metastasis, and resistance to anti-cancer therapies. Elucidation of how these CSCs maintain their stemness features is essential for the development of CSCs-based therapy. In this review, we summarize the present knowledge of intrinsic molecules and signaling pathways involved in hepatic CSCs, especially the CSC surface markers and associated signaling in regulating the stemness characteristics and the heterogeneous subpopulations within the CSC pool. In addition, we recapitulate the effects of crucial extrinsic cellular components in the tumor microenvironment, including stromal cells and immune cells, on the modulation of hepatic CSCs. Finally, we synopsize the currently valuable CSCs-targeted therapy strategies based on intervention in these intrinsic and extrinsic molecular mechanisms, in the hope of shedding light on better clinical management of HCC patients.

摘要

肝细胞癌 (HCC) 仍然是最主要的肝癌类型,由于其诊断较晚和高复发率,预后极差。 HCC 复发和转移的罪魁祸首之一是癌症干细胞 (CSC) 的存在,CSC 是肿瘤内具有强大干细胞特性的一小部分癌细胞。 CSCs 在肿瘤异质性构成、肿瘤发生、肿瘤复发、转移和对抗癌治疗的耐药性中起着至关重要的作用。阐明这些 CSCs 如何维持其干细胞特性对于基于 CSC 的治疗的发展至关重要。在这篇综述中,我们总结了涉及肝 CSC 的内在分子和信号通路的现有知识,特别是 CSC 表面标记物和相关信号通路在调节干细胞特性和 CSC 池内异质亚群中的作用。此外,我们回顾了肿瘤微环境中关键细胞外成分(包括基质细胞和免疫细胞)对肝 CSC 调节的影响。最后,我们综合了目前基于干预这些内在和外在分子机制的有价值的 CSC 靶向治疗策略,希望为 HCC 患者的临床管理提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/4b90a716fa65/ijms-23-12327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/d288db8fc87d/ijms-23-12327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/4bb93823d679/ijms-23-12327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/4b90a716fa65/ijms-23-12327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/d288db8fc87d/ijms-23-12327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/4bb93823d679/ijms-23-12327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e2/9604119/4b90a716fa65/ijms-23-12327-g003.jpg

相似文献

1
Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.肝癌中的肿瘤干细胞:干性调控的内在和外在分子机制。
Int J Mol Sci. 2022 Oct 14;23(20):12327. doi: 10.3390/ijms232012327.
2
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.针对肝癌肿瘤干细胞的免疫治疗。
Theranostics. 2021 Jan 19;11(7):3489-3501. doi: 10.7150/thno.54648. eCollection 2021.
3
Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.脂多糖通过激活NF-κB/HIF-1α信号通路维持CD133(+)肝癌细胞的干性。
Cancer Lett. 2016 Aug 10;378(2):131-41. doi: 10.1016/j.canlet.2016.05.014. Epub 2016 May 18.
4
Novel therapeutic strategies for targeting liver cancer stem cells.靶向肝癌干细胞的新型治疗策略。
Int J Biol Sci. 2011 Apr 26;7(5):517-35. doi: 10.7150/ijbs.7.517.
5
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.IFI44L 是一种新型的人肝癌肿瘤抑制因子,通过调节 met/Src 信号通路影响肿瘤干细胞特性、转移和耐药性。
BMC Cancer. 2018 May 30;18(1):609. doi: 10.1186/s12885-018-4529-9.
6
Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.靶向谷氨酰胺酶 1 通过增加活性氧物种和抑制 Wnt/β-连环蛋白通路来减弱肝癌的干性特征。
EBioMedicine. 2019 Jan;39:239-254. doi: 10.1016/j.ebiom.2018.11.063. Epub 2018 Dec 13.
7
HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.HBX 诱导的 miR-5188 抑制 FOXO1 从而刺激β-catenin 核转位并促进肝癌肿瘤干细胞特性。
Theranostics. 2019 Oct 12;9(25):7583-7598. doi: 10.7150/thno.37717. eCollection 2019.
8
Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.肝癌中的癌症干细胞——从起源到临床意义。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):26-44. doi: 10.1038/s41575-021-00508-3. Epub 2021 Sep 9.
9
Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma.肝癌中的癌症干细胞和肝星状细胞。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231163677. doi: 10.1177/15330338231163677.
10
Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma.肝细胞癌中癌症干细胞与血管生成之间的正反馈回路。
Cancer Lett. 2016 Sep 1;379(2):213-9. doi: 10.1016/j.canlet.2016.03.014. Epub 2016 Apr 20.

引用本文的文献

1
Transcription factor JUNB is required for transformation of EpCAM-positive hepatocellular carcinoma (HCC) cells into CD90-positive HCC cells in vitro.转录因子JUNB是体外将EpCAM阳性肝癌(HCC)细胞转化为CD90阳性HCC细胞所必需的。
Cell Death Dis. 2025 Apr 19;16(1):319. doi: 10.1038/s41419-025-07602-3.
2
Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin.肝细胞癌患者肿瘤大小与生存的相关因素:血小板-淋巴细胞比值、门静脉血栓形成及白蛋白的意义
Oncology. 2025 Apr 8:1-11. doi: 10.1159/000545636.
3
M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4.

本文引用的文献

1
FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells.FOXM1-CD44 信号通路对于人肝癌细胞获得regorafenib 耐药性至关重要。
Int J Mol Sci. 2022 Jul 14;23(14):7782. doi: 10.3390/ijms23147782.
2
Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells.肝癌肿瘤干细胞对自然杀伤细胞的免疫逃逸。
Ann Surg Oncol. 2022 Nov;29(12):7423-7433. doi: 10.1245/s10434-022-12220-w. Epub 2022 Jul 25.
3
A novel nitidine chloride nanoparticle overcomes the stemness of CD133EPCAM Huh7 hepatocellular carcinoma cells for liver cancer therapy.
m6A修饰的BFSP1通过上调原肌球蛋白4诱导有氧糖酵解,促进肝癌生长和转移。
Mol Biomed. 2025 Mar 18;6(1):17. doi: 10.1186/s43556-025-00256-9.
4
Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies.与肿瘤起始细胞出现相关的原发性肝癌发生的危险因素:有前景的预防性治疗的新靶点。
eGastroenterology. 2023 Aug 9;1(1):e100010. doi: 10.1136/egastro-2023-100010. eCollection 2023 Jun.
5
A Novel Glycoengineered Humanized Antibody Targeting DLK1 Exhibits Potent Anti-Tumor Activity in DLK1-Expressing Liver Cancer Cell Xenograft Models.一种靶向DLK1的新型糖基工程化人源化抗体在表达DLK1的肝癌细胞异种移植模型中展现出强大的抗肿瘤活性。
Int J Mol Sci. 2024 Dec 19;25(24):13627. doi: 10.3390/ijms252413627.
6
Regulatory factor X-5/SCL/TAL1 interruption site axis promotes aerobic glycolysis and hepatocellular carcinoma cell stemness.调节因子X-5/SCL/TAL1中断位点轴促进有氧糖酵解和肝癌细胞干性。
Kaohsiung J Med Sci. 2025 Jan;41(1):e12922. doi: 10.1002/kjm2.12922. Epub 2024 Dec 24.
7
Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein.深入了解乙型肝炎病毒X蛋白调控肝癌干细胞的机制。
Infect Agent Cancer. 2024 Nov 11;19(1):56. doi: 10.1186/s13027-024-00618-y.
8
Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application.肝细胞癌中 DNA 甲基化的综合回顾和最新分析:从基础研究到临床应用。
Clin Transl Med. 2024 Nov;14(11):e70066. doi: 10.1002/ctm2.70066.
9
Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis.癌症干细胞标志物表达对肝细胞癌不良结局的诊断价值及其与预后的关联:一项贝叶斯网络荟萃分析
Oncol Lett. 2024 Sep 6;28(5):536. doi: 10.3892/ol.2024.14669. eCollection 2024 Nov.
10
Promotion of hepatocellular carcinoma stemness and progression by abnormal spindle-like microcephaly-associated protein via the Wnt/β-catenin pathway.异常纺锤样小头畸形相关蛋白通过Wnt/β-连环蛋白信号通路促进肝细胞癌干性及进展
J Gastrointest Oncol. 2024 Aug 31;15(4):1613-1626. doi: 10.21037/jgo-24-406. Epub 2024 Aug 15.
一种新型盐酸黄连碱纳米颗粒克服了 CD133EPCAM Huh7 肝癌细胞的干性,可用于肝癌治疗。
BMC Pharmacol Toxicol. 2022 Jul 12;23(1):48. doi: 10.1186/s40360-022-00589-z.
4
A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer.一种功能性筛选方法鉴定出一种新型有机硒化合物靶向癌症干细胞:在肝癌中抑制 c-Myc 转录活性的作用。
Adv Sci (Weinh). 2022 Aug;9(22):e2201166. doi: 10.1002/advs.202201166. Epub 2022 Jun 2.
5
Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.靶向 TROY 介导的 P85a/AKT/TBX3 信号通路抑制肝癌肿瘤干细胞特性并提高治疗应答。
J Exp Clin Cancer Res. 2022 May 25;41(1):182. doi: 10.1186/s13046-022-02401-6.
6
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM and CD90 Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model.在原位小鼠模型中,联合靶向AKT和mTOR可抑制EpCAM和CD90人肝癌细胞的肿瘤形成。
Cancers (Basel). 2022 Apr 8;14(8):1882. doi: 10.3390/cancers14081882.
7
Liver tumor-initiating cells initiate the formation of a stiff cancer stem cell microenvironment niche by secreting LOX.肝肿瘤起始细胞通过分泌 LOX 启动坚硬的癌症干细胞微环境龛的形成。
Carcinogenesis. 2022 Sep 19;43(8):766-778. doi: 10.1093/carcin/bgac035.
8
Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma.单细胞转录组学分析揭示了肿瘤内异质性,并确定了一个与肝细胞癌预后相关的基因特征。
Biosci Rep. 2022 Feb 25;42(2). doi: 10.1042/BSR20212560.
9
Single-Cell Sequencing of Hepatocellular Carcinoma Reveals Cell Interactions and Cell Heterogeneity in the Microenvironment.肝细胞癌的单细胞测序揭示了微环境中的细胞相互作用和细胞异质性。
Int J Gen Med. 2021 Dec 22;14:10141-10153. doi: 10.2147/IJGM.S338090. eCollection 2021.
10
Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCC.单细胞RNA测序分析鉴定出一种介导肝癌对索拉非尼治疗耐药的非编码RNA。
Mol Cancer. 2022 Jan 3;21(1):6. doi: 10.1186/s12943-021-01473-w.